SEC alleges Rep. Christopher Collins, R-N.Y., gave information to his son in June 2017 about clinical failure of trial drug, son sold 1.4 million shares and spread info through family. pic.twitter.com/Rgvcz8hSxX

— Todd Ruger (@ToddRuger) August 8, 2018